Aclaris Therapeutics, Inc. Annual Depreciation in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Aclaris Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2013 to 2023.
  • Aclaris Therapeutics, Inc. Depreciation for the quarter ending September 30, 2024 was $200K, unchanged year-over-year.
  • Aclaris Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2024 was $800K, a 14.3% increase year-over-year.
  • Aclaris Therapeutics, Inc. annual Depreciation for 2023 was $800K, a 14.3% increase from 2022.
  • Aclaris Therapeutics, Inc. annual Depreciation for 2022 was $700K, a 12.5% decline from 2021.
  • Aclaris Therapeutics, Inc. annual Depreciation for 2021 was $800K, a 27.3% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $800K +$100K +14.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $700K -$100K -12.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $800K -$300K -27.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $1.1M -$400K -26.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $1.5M +$300K +25% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $1.2M +$830K +224% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $370K +$250K +208% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
2016 $120K +$30K +33.3% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-18
2015 $90K +$78K +650% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 $12K +$1K +9.09% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
2013 $11K Jan 1, 2013 Dec 31, 2013 10-K 2016-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.